Diabetes
Screening program detects more colorectal cancers in adults with diabetes
A colorectal cancer screening program in Denmark that used fecal immunochemical testing detected more cases among adults with diabetes and more cases at stage I of the disease than among those without diabetes, according to data published in Diabetic Medicine.
Diabetic retinopathy prevalence increases over time in pediatric type 2 diabetes
The prevalence of diabetic retinopathy among children and adolescents with type 2 diabetes greatly increases 5 years after diabetes diagnosis, according to findings from a systematic review and meta-analysis.
Placental perfusion, maternal visceral adiposity may predict gestational diabetes
MRI-determined placental volume, perfusion and visceral adiposity in early pregnancy were significantly associated with gestational diabetes, according to a prospective study published in The Journal of Clinical Endocrinology & Metabolism.
Sanofi announces insulin price cuts, $35 monthly cap for people with commercial insurance
Following on the heels of Eli Lilly and Novo Nordisk, Sanofi announced it will reduce the price of two of its branded insulins as well as cap out-of-pocket costs at $35 per month for people with commercial health insurance.
Low sex hormones may increase likelihood for transition to diabetes among Hispanic adults
Low testosterone among men and low sex hormone-binding globulin among women are associated with progression from prediabetes to diabetes, according to a study published in The Journal of Clinical Endocrinology & Metabolism.
Novo Nordisk to cut prices by up to 75% for some insulin products in 2024
Novo Nordisk is the latest company to announce a large reduction in insulin prices as it stated it will cut prices for multiple insulin products by up to 75% in 2024.
Q&A: In patients with obesity and type 2 diabetes, OMA advocates to ‘treat obesity first’
The Obesity Medicine Association recently published a new clinical practice statement encouraging clinicians to prioritize the treatment of obesity in patients who also have type 2 diabetes mellitus without acute illness.
Cognitive behavioral therapy mobile app improves health behavior in patients with diabetes
NEW ORLEANS — With the use of cognitive behavioral therapy, a smartphone app helped patients with type 2 diabetes reduce HbA1c with less medication and insulation intensification vs. controls, a speaker reported.
More than 20% of patients at high risk for CVD reject statin therapy
Many patients at risk for CVD, particularly women, did not accept statin therapy recommended to them by their health care provider, data show.
FDA clears two CGM sensors for integration with automated insulin delivery systems
The FDA has granted clearance to allow two integrated continuous glucose monitoring sensors to be used with automated insulin delivery systems, according to an industry press release.